製品名
MILLIPLEX® Human CD8+ T Cell Panel,
Quality Segment
description
Configurable Human CD8+ T Cell 17-Plex Panel
species reactivity
human
packaging
pkg of 1 ea
manufacturer/tradename
Milliplex®
assay range
standard curve range: 0.4-1,500 pg/mL
(IL-6), standard curve range: 0.5-2,000 pg/mL
(TNFα), standard curve range: 1-3,500 pg/mL
(MIP-1α), standard curve range: 1-5,000 pg/mL
(Granzyme B), standard curve range: 1-5,000 pg/mL
(IFNγ), standard curve range: 1-5,000 pg/mL
(IL-5), standard curve range: 10-50,000 pg/mL
(Perforin), standard curve range: 10-50,000 pg/mL
(sFasL), standard curve range: 2-10,000 pg/mL
(IL-4), standard curve range: 2-10,000 pg/mL
(sCD137), standard curve range: 2-7,500 pg/mL
(IL-13), standard curve range: 2-7,500 pg/mL
(IL-2), standard curve range: 20-100,000 pg/mL
(Granzyme A), standard curve range: 4-15,000 pg/mL
(GM-CSF), standard curve range: 400-1,650,000 pg/mL
(sFas), standard curve range: 5-20,000 pg/mL
(IL-10), standard curve range: 7-30,000 pg/mL
(MIP-1β)
technique(s)
multiplexing: suitable
input
cell culture supernatant(s)
plasma
detection method
fluorometric (Luminex® xMAP® technology)
shipped in
wet ice
storage temp.
2-8°C
General description
Application
Analytes included: GM-CSF, sCD137, IFNγ, sFas, sFasL, Granzyme A, Granzyme B, IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, MIP-1α, MIP-1β, TNF-α, Perforin
Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.
Features and Benefits
- Enhanced Understanding of Immune Response: The ability to measure multiple cytokines and chemokines associated with CD8+ T cell activity aids researchers in understanding the immune response in various conditions, including infections and cancers. Streamlined.
- Research Process: The overnight run time and simple sample preparation facilitate a more efficient research workflow, allowing for quicker data analysis and decision-making.
- Configurable Options for Diverse Research Needs: The ability to configure the panel ensures that researchers can adapt the kit to their specific study requirements, making it a versatile tool in immunology research.
- Conservation of Valuable Samples: By quantifying multiple analytes from a single sample, researchers can conserve precious sample volume, which is especially important in studies involving limited or difficult-to-obtain samples.
- Comprehensive Analyte Detection: The panel includes 15 key analytes relevant to CD8+ T cell function and activity, such as GM-CSF, IFNγ, IL-2, Granzyme A, and Perforin, allowing for a detailed immune response analysis.
Legal Information
Disclaimer
Label License/Sticker for Assay Product:
By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.
Still not finding the right product?
Explore all of our products under MILLIPLEX® Human CD8+ T Cell Panel
signalword
Danger
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
target_organs
Respiratory Tract
保管分類
10 - Combustible liquids
wgk
WGK 3
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Please refer to KIT Component information
pdsc
Please refer to KIT Component information
prtr
Please refer to KIT Component information
fsl
Please refer to KIT Component information
ishl_indicated
Please refer to KIT Component information
ishl_notified
Please refer to KIT Component information
cart
キットコンポーネントの情報を参照してください
jan
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。



